Cas 849094-13-9,[2-(tert-butyldimethylsilanyloxy)-1(R)-(4-fluorobenzylsulfanylmethyl)ethyl]-(2,2,2-trifluoroethylidene)amine

849094-13-9

Post Buying Request

Basic information

Product Name: [2-(tert-butyldimethylsilanyloxy)-1(R)-(4-fluorobenzylsulfanylmethyl)ethyl]-(2,2,2-trifluoroethylidene)amine
Synonyms: [2-(tert-butyldimethylsilanyloxy)-1(R)-(4-fluorobenzylsulfanylmethyl)ethyl]-(2,2,2-trifluoroethylidene)amine
CAS NO:849094-13-9
Molecular Formula:
Molecular Weight: 409.564
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [2-(tert-butyldimethylsilanyloxy)-1(R)-(4-fluorobenzylsulfanylmethyl)ethyl]-(2,2,2-trifluoroethylidene)amine(CAS DataBase Reference)
NIST Chemistry Reference: [2-(tert-butyldimethylsilanyloxy)-1(R)-(4-fluorobenzylsulfanylmethyl)ethyl]-(2,2,2-trifluoroethylidene)amine(849094-13-9)
EPA Substance Registry System: [2-(tert-butyldimethylsilanyloxy)-1(R)-(4-fluorobenzylsulfanylmethyl)ethyl]-(2,2,2-trifluoroethylidene)amine(849094-13-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 849094-13-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

849094-13-9 Suppliers

Recommended suppliers

849094-13-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 849094-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,0,9 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 849094-13:
(8*8)+(7*4)+(6*9)+(5*0)+(4*9)+(3*4)+(2*1)+(1*3)=199
199 % 10 = 9
So 849094-13-9 is a valid CAS Registry Number.

849094-13-9Upstream product

849094-13-9Downstream Products

849094-13-9Relevant academic research and scientific papers

HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page/Page column 88, (2008/06/13)

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 849094-13-9